<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00890136</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00017777</org_study_id>
    <nct_id>NCT00890136</nct_id>
  </id_info>
  <brief_title>Chronic Obstructive Pulmonary Disease (COPD) and Domestic Endotoxin (CODE)</brief_title>
  <acronym>CODE</acronym>
  <official_title>COpd and Domestic Endotoxin (CODE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Environmental Health Sciences (NIEHS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aims to characterize the independent effect of domestic endotoxin exposure on&#xD;
      health status, as well as pulmonary and systemic inflammation, in former smokers with COPD.&#xD;
      Positive findings from this study would be clinically relevant, as they would provide&#xD;
      evidence to support aggressive reduction of ongoing endotoxin exposure in patients with COPD.&#xD;
      The investigators also hope to make a methodological advance in the field of endotoxin&#xD;
      exposure assessment by elucidating whether settled dust and/or airborne endotoxin&#xD;
      measurements are the more relevant exposure of interest in epidemiological studies of&#xD;
      respiratory disease. To fulfill the specific aims, the investigators will conduct a&#xD;
      longitudinal study, including 75 former smokers with COPD. All subjects will have indoor air&#xD;
      monitoring, in-home settled dust collections, home inspections as well as assessments of&#xD;
      health status, quality of life (QOL), lung function and pulmonary and systemic inflammation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2008</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>statistical analysis</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <enrollment type="Actual">84</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood, sputum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Both Male and Female 40 years and older&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient reported physician diagnosis of COPD/Chronic Bronchitis/Emphysema&#xD;
&#xD;
          -  Cigarette Smoking &gt; 10 pack-years&#xD;
&#xD;
          -  Age &gt; 40 years&#xD;
&#xD;
          -  Has not smoked &gt; 1 year&#xD;
&#xD;
          -  Post BD FEV1/FVC â‰¤ 70%&#xD;
&#xD;
          -  Post BD FEV1 (% predicted) 30-80%&#xD;
&#xD;
          -  Ability and willingness to provide consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non- English speaking&#xD;
&#xD;
          -  Planning to move or live away from the home during the study period&#xD;
&#xD;
          -  Co-morbid illnesses such as:&#xD;
&#xD;
               -  Current physician diagnosis of Asthma&#xD;
&#xD;
               -  Other pulmonary diseases&#xD;
&#xD;
               -  Systemic disease requiring treatment with immunosuppressive agents&#xD;
&#xD;
               -  Known alpha-1 antitrypsin deficiency&#xD;
&#xD;
               -  Occupational exposure with high endotoxin exposure&#xD;
&#xD;
          -  Within the last 6 months Use of oral corticosteroids&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nadia Hansel, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Karina Romero</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 27, 2009</study_first_submitted>
  <study_first_submitted_qc>April 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2009</study_first_posted>
  <last_update_submitted>June 21, 2019</last_update_submitted>
  <last_update_submitted_qc>June 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Obstructive Pulmonary Disease (COPD)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

